help button home button Am J Pathol Angiogenesis Meeting
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baba, M.
Right arrow Articles by Iwatsubo, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baba, M.
Right arrow Articles by Iwatsubo, T.

American Journal of Pathology, Vol 152, 879-884, Copyright © 1998 by American Society for Investigative Pathology

REGULAR ARTICLES

Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies

M Baba, S Nakajo, PH Tu, T Tomita, K Nakaya, VM Lee, JQ Trojanowski and T Iwatsubo
Department of Neuropathology and Neuroscience, Graduate School of Pharmaceutical Sciences, University of Tokyo, Japan.

Lewy bodies (LBs) are hallmark lesions of degenerating neurons in the brains of patients with Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Recently, a point mutation in the gene encoding the presynaptic alpha-synuclein protein was identified in some autosomal- dominantly inherited familial PD pedigrees, and light microscopic studies demonstrated alpha-synuclein immunoreactivity in LBs of sporadic PD and DLB. To characterize alpha-synuclein in LBs, we raised monoclonal antibodies (MAbs) to LBs purified from DLB brains and obtained a MAb specific for alpha-synuclein that intensely labeled LBs. Light and electron microscopic immunocytochemical studies performed with this MAb as well as other antibodies to alpha-and beta-synuclein showed that alpha-synuclein, but not beta-synuclein, is a component of LBs in sporadic PD and DLB. Western blot analyses of highly purified LBs from DLB brains showed that full-length as well as partially truncated and insoluble aggregates of alpha-synuclein are deposited in LBs. Thus, these data strongly implicate alpha-synuclein in the formation of LBs and the selective degeneration of neurons in sporadic PD and DLB.


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
T. Kabuta, A. Furuta, S. Aoki, K. Furuta, and K. Wada
Aberrant Interaction between Parkinson Disease-associated Mutant UCH-L1 and the Lysosomal Receptor for Chaperone-mediated Autophagy
J. Biol. Chem., August 29, 2008; 283(35): 23731 - 23738.
[Abstract] [Full Text] [PDF]

Home page
 Protein Sci.Home page
R. C. Rivers, J. R. Kumita, G. G. Tartaglia, M. M. Dedmon, A. Pawar, M. Vendruscolo, C. M. Dobson, and J. Christodoulou
Molecular determinants of the aggregation behavior of {alpha}- and {beta}-synuclein
Protein Sci., May 1, 2008; 17(5): 887 - 898.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
W. Zhou, J. B. Milder, and C. R. Freed
Transgenic Mice Overexpressing Tyrosine-to-Cysteine Mutant Human {alpha}-Synuclein: A PROGRESSIVE NEURODEGENERATIVE MODEL OF DIFFUSE LEWY BODY DISEASE
J. Biol. Chem., April 11, 2008; 283(15): 9863 - 9870.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
S. Orimo, T. Uchihara, A. Nakamura, F. Mori, A. Kakita, K. Wakabayashi, and H. Takahashi
Axonal {alpha}-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease
Brain, March 1, 2008; 131(3): 642 - 650.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. Rott, R. Szargel, J. Haskin, V. Shani, A. Shainskaya, I. Manov, E. Liani, E. Avraham, and S. Engelender
Monoubiquitylation of {alpha}-Synuclein by Seven in Absentia Homolog (SIAH) Promotes Its Aggregation in Dopaminergic Cells
J. Biol. Chem., February 8, 2008; 283(6): 3316 - 3328.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
H. Kaneko, A. Kakita, K. Kasuga, H. Nozaki, A. Ishikawa, A. Miyashita, R. Kuwano, G. Ito, T. Iwatsubo, H. Takahashi, et al.
Enhanced Accumulation of Phosphorylated {alpha}-Synuclein and Elevated -Amyloid 42/40 Ratio Caused by Expression of the Presenilin-1 {Delta}T440 Mutant Associated with Familial Lewy Body Disease and Variant Alzheimer's Disease
J. Neurosci., November 28, 2007; 27(48): 13092 - 13097.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
N. Exner, B. Treske, D. Paquet, K. Holmstrom, C. Schiesling, S. Gispert, I. Carballo-Carbajal, D. Berg, H.-H. Hoepken, T. Gasser, et al.
Loss-of-Function of Human PINK1 Results in Mitochondrial Pathology and Can Be Rescued by Parkin
J. Neurosci., November 7, 2007; 27(45): 12413 - 12418.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Wei, M. Fujita, M. Nakai, M. Waragai, K. Watabe, H. Akatsu, E. Rockenstein, E. Masliah, and M. Hashimoto
Enhanced Lysosomal Pathology Caused by beta-Synuclein Mutants Linked to Dementia with Lewy Bodies
J. Biol. Chem., September 28, 2007; 282(39): 28904 - 28914.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
M. T. Fodero-Tavoletti, D. P. Smith, C. A. McLean, P. A. Adlard, K. J. Barnham, L. E. Foster, L. Leone, K. Perez, M. Cortes, J. G. Culvenor, et al.
In Vitro Characterization of Pittsburgh Compound-B Binding to Lewy Bodies
J. Neurosci., September 26, 2007; 27(39): 10365 - 10371.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
T. Murakami, Y. Moriwaki, T. Kawarabayashi, M. Nagai, Y. Ohta, K. Deguchi, T. Kurata, N. Morimoto, Y. Takehisa, E. Matsubara, et al.
PINK1, a gene product of PARK6, accumulates in {alpha}-synucleinopathy brains
J. Neurol. Neurosurg. Psychiatry, June 1, 2007; 78(6): 653 - 654.
[Full Text] [PDF]

Home page
 Protein Sci.Home page
S. Zibaee, O. S. Makin, M. Goedert, and L. C. Serpell
A simple algorithm locates beta-strands in the amyloid fibril core of {alpha}-synuclein, Abeta, and tau using the amino acid sequence alone
Protein Sci., May 1, 2007; 16(5): 906 - 918.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
B. M. Dufty, L. R. Warner, S. T. Hou, S. X. Jiang, T. Gomez-Isla, K. M. Leenhouts, J. T. Oxford, M. B. Feany, E. Masliah, and T. T. Rohn
Calpain-Cleavage of {alpha}-Synuclein: Connecting Proteolytic Processing to Disease-Linked Aggregation
Am. J. Pathol., May 1, 2007; 170(5): 1725 - 1738.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
M. Periquet, T. Fulga, L. Myllykangas, M. G. Schlossmacher, and M. B. Feany
Aggregated {alpha}-Synuclein Mediates Dopaminergic Neurotoxicity In Vivo
J. Neurosci., March 21, 2007; 27(12): 3338 - 3346.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
C. F. Lippa, J. E. Duda, M. Grossman, H. I. Hurtig, D. Aarsland, B. F. Boeve, D. J. Brooks, D. W. Dickson, B. Dubois, M. Emre, et al.
DLB and PDD boundary issues: Diagnosis, treatment, molecular pathology, and biomarkers
Neurology, March 13, 2007; 68(11): 812 - 819.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
E. H. Norris, K. Uryu, S. Leight, B. I. Giasson, J. Q. Trojanowski, and V. M.-Y. Lee
Pesticide Exposure Exacerbates {alpha}-Synucleinopathy in an A53T Transgenic Mouse Model
Am. J. Pathol., February 1, 2007; 170(2): 658 - 666.
[Abstract] [Full Text] [PDF]

Home page
 AM J ALZHEIMERS DIS OTHER DEMENHome page
C. F. Lippa
An Individualized Approach to Treatment for Alzheimer's Disease, Pick's Disease, and Other Dementias.
American Journal of Alzheimer's Disease and Other Dementias, October 1, 2006; 21(5): 354 - 359.
[Abstract] [PDF]

Home page
 J. Neurosci.Home page
J. R. Mazzulli, A. J. Mishizen, B. I. Giasson, D. R. Lynch, S. A. Thomas, A. Nakashima, T. Nagatsu, A. Ota, and H. Ischiropoulos
Cytosolic Catechols Inhibit {alpha}-Synuclein Aggregation and Facilitate the Formation of Intracellular Soluble Oligomeric Intermediates
J. Neurosci., September 27, 2006; 26(39): 10068 - 10078.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
S. Arawaka, M. Wada, S. Goto, H. Karube, M. Sakamoto, C.-H. Ren, S. Koyama, H. Nagasawa, H. Kimura, T. Kawanami, et al.
The Role of G-Protein-Coupled Receptor Kinase 5 in Pathogenesis of Sporadic Parkinson's Disease
J. Neurosci., September 6, 2006; 26(36): 9227 - 9238.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
K. Tanji, T. Tanaka, F. Mori, K. Kito, H. Takahashi, K. Wakabayashi, and T. Kamitani
NUB1 Suppresses the Formation of Lewy Body-Like Inclusions by Proteasomal Degradation of Synphilin-1
Am. J. Pathol., August 1, 2006; 169(2): 553 - 565.
[Abstract] [Full Text] [PDF]

Home page
 Protein Sci.Home page
M. Bisaglia, A. Trolio, M. Bellanda, E. Bergantino, L. Bubacco, and S. Mammi
Structure and topology of the non-amyloid-beta component fragment of human {alpha}-synuclein bound to micelles: Implications for the aggregation process.
Protein Sci., June 1, 2006; 15(6): 1408 - 1416.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
K. St. P. McNaught, T. Jackson, R. JnoBaptiste, A. Kapustin, and C. W. Olanow
Proteasomal dysfunction in sporadic Parkinson's disease
Neurology, May 23, 2006; 66(10_suppl_4): S37 - S49.
[Abstract] [Full Text]

Home page
 J. Neurosci.Home page
G. K. Tofaris, P. Garcia Reitbock, T. Humby, S. L. Lambourne, M. O'Connell, B. Ghetti, H. Gossage, P. C. Emson, L. S. Wilkinson, M. Goedert, et al.
Pathological Changes in Dopaminergic Nerve Cells of the Substantia Nigra and Olfactory Bulb in Mice Transgenic for Truncated Human {alpha}-Synuclein(1-120): Implications for Lewy Body Disorders
J. Neurosci., April 12, 2006; 26(15): 3942 - 3950.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
R. von Coelln, B. Thomas, S. A. Andrabi, K. L. Lim, J. M. Savitt, R. Saffary, W. Stirling, K. Bruno, E. J. Hess, M. K. Lee, et al.
Inclusion body formation and neurodegeneration are parkin independent in a mouse model of alpha-synucleinopathy.
J. Neurosci., April 5, 2006; 26(14): 3685 - 3696.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
J. B. Leverenz, M. A. Fishel, E. R. Peskind, T. J. Montine, D. Nochlin, E. Steinbart, M. A. Raskind, G. D. Schellenberg, T. D. Bird, and D. Tsuang
Lewy Body Pathology in Familial Alzheimer Disease: Evidence for Disease- and Mutation-Specific Pathologic Phenotype.
Arch Neurol, March 1, 2006; 63(3): 370 - 376.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
K. Uryu, C. Richter-Landsberg, W. Welch, E. Sun, O. Goldbaum, E. H. Norris, C.-T. Pham, I. Yazawa, K. Hilburger, M. Micsenyi, et al.
Convergence of Heat Shock Protein 90 with Ubiquitin in Filamentous {alpha}-Synuclein Inclusions of {alpha}-Synucleinopathies
Am. J. Pathol., March 1, 2006; 168(3): 947 - 961.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Ryo, T. Togo, T. Nakai, A. Hirai, M. Nishi, A. Yamaguchi, K. Suzuki, Y. Hirayasu, H. Kobayashi, K. Perrem, et al.
Prolyl-isomerase Pin1 Accumulates in Lewy Bodies of Parkinson Disease and Facilitates Formation of {alpha}-Synuclein Inclusions
J. Biol. Chem., February 17, 2006; 281(7): 4117 - 4125.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C. W. Shults
Lewy bodies
PNAS, February 7, 2006; 103(6): 1661 - 1668.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Kuwahara, A. Koyama, K. Gengyo-Ando, M. Masuda, H. Kowa, M. Tsunoda, S. Mitani, and T. Iwatsubo
Familial Parkinson Mutant {alpha}-Synuclein Causes Dopamine Neuron Dysfunction in Transgenic Caenorhabditis elegans
J. Biol. Chem., January 6, 2006; 281(1): 334 - 340.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Y. Shin, J. Klucken, C. Patterson, B. T. Hyman, and P. J. McLean
The Co-chaperone Carboxyl Terminus of Hsp70-interacting Protein (CHIP) Mediates {alpha}-Synuclein Degradation Decisions between Proteasomal and Lysosomal Pathways
J. Biol. Chem., June 24, 2005; 280(25): 23727 - 23734.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C.-W. Liu, B. I. Giasson, K. A. Lewis, V. M. Lee, G. N. DeMartino, and P. J. Thomas
A Precipitating Role for Truncated {alpha}-Synuclein and the Proteasome in {alpha}-Synuclein Aggregation: IMPLICATIONS FOR PATHOGENESIS OF PARKINSON DISEASE
J. Biol. Chem., June 17, 2005; 280(24): 22670 - 22678.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. H. Norris, B. I. Giasson, R. Hodara, S. Xu, J. Q. Trojanowski, H. Ischiropoulos, and V. M.-Y. Lee
Reversible Inhibition of {alpha}-Synuclein Fibrillization by Dopaminochrome-mediated Conformational Alterations
J. Biol. Chem., June 3, 2005; 280(22): 21212 - 21219.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Zhong, Y. Tan, A. Zhou, Q. Yu, and J. Zhou
RING Finger Ubiquitin-Protein Isopeptide Ligase Nrdp1/FLRF Regulates Parkin Stability and Activity
J. Biol. Chem., March 11, 2005; 280(10): 9425 - 9430.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. B. Cole, D. D. Murphy, J. Lebowitz, L. Di Noto, R. L. Levine, and R. L. Nussbaum
Metal-catalyzed Oxidation of {alpha}-Synuclein: HELPING TO DEFINE THE RELATIONSHIP BETWEEN OLIGOMERS, PROTOFIBRILS, AND FILAMENTS
J. Biol. Chem., March 11, 2005; 280(10): 9678 - 9690.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
P. K. Auluck, M. C. Meulener, and N. M. Bonini
Mechanisms of Suppression of {alpha}-Synuclein Neurotoxicity by Geldanamycin in Drosophila
J. Biol. Chem., January 28, 2005; 280(4): 2873 - 2878.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
A. Popescu, C. F. Lippa, V. M.-Y. Lee, and J. Q. Trojanowski
Lewy Bodies in the Amygdala: Increase of {alpha}-Synuclein Aggregates in Neurodegenerative Diseases With Tau-Based Inclusions
Arch Neurol, December 1, 2004; 61(12): 1915 - 1919.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. C. Lee, R. Langen, P. A. Hummel, H. B. Gray, and J. R. Winkler
{alpha}-Synuclein structures from fluorescence energy-transfer kinetics: Implications for the role of the protein in Parkinson's disease
PNAS, November 23, 2004; 101(47): 16466 - 16471.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. Hodara, E. H. Norris, B. I. Giasson, A. J. Mishizen-Eberz, D. R. Lynch, V. M.-Y. Lee, and H. Ischiropoulos
Functional Consequences of {alpha}-Synuclein Tyrosine Nitration: DIMINISHED BINDING TO LIPID VESICLES AND INCREASED FIBRIL FORMATION
J. Biol. Chem., November 12, 2004; 279(46): 47746 - 47753.
[Abstract] [Full Text] [PDF]

Home page
 J Geriatr Psychiatry NeurolHome page
B. F. Boeve, M. H. Silber, and T. J. Ferman
REM Sleep Behavior Disorder in Parkinson's Disease and Dementia with Lewy Bodies
J Geriatr Psychiatry Neurol, September 1, 2004; 17(3): 146 - 157.
[Abstract] [PDF]

Home page
 J. Biol. Chem.Home page
S. V. Kalivendi, S. Cunningham, S. Kotamraju, J. Joseph, C. J. Hillard, and B. Kalyanaraman
{alpha}-Synuclein Up-regulation and Aggregation during MPP+-induced Apoptosis in Neuroblastoma Cells: INTERMEDIACY OF TRANSFERRIN RECEPTOR IRON AND HYDROGEN PEROXIDE
J. Biol. Chem., April 9, 2004; 279(15): 15240 - 15247.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
A. SIDHU, C. WERSINGER, and P. VERNIER
Does {alpha}-synuclein modulate dopaminergic synaptic content and tone at the synapse?
FASEB J, April 1, 2004; 18(6): 637 - 647.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. Lindersson, R. Beedholm, P. Hojrup, T. Moos, W. Gai, K. B. Hendil, and P. H. Jensen
Proteasomal Inhibition by {alpha}-Synuclein Filaments and Oligomers
J. Biol. Chem., March 26, 2004; 279(13): 12924 - 12934.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
G. Lee, M. Tanaka, K. Park, S. S. Lee, Y. M. Kim, E. Junn, S.-H. Lee, and M. M. Mouradian
Casein Kinase II-mediated Phosphorylation Regulates {alpha}-Synuclein/Synphilin-1 Interaction and Inclusion Body Formation
J. Biol. Chem., February 20, 2004; 279(8): 6834 - 6839.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. C. Pawlyk, B. I. Giasson, D. M. Sampathu, F. A. Perez, K. L. Lim, V. L. Dawson, T. M. Dawson, R. D. Palmiter, J. Q. Trojanowski, and V. M.-Y. Lee
Novel Monoclonal Antibodies Demonstrate Biochemical Variation of Brain Parkin with Age
J. Biol. Chem., November 28, 2003; 278(48): 48120 - 48128.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Necula, C. N. Chirita, and J. Kuret
Rapid Anionic Micelle-mediated {alpha}-Synuclein Fibrillization in Vitro
J. Biol. Chem., November 21, 2003; 278(47): 46674 - 46680.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
G. K. Tofaris, A. Razzaq, B. Ghetti, K. S. Lilley, and M. G. Spillantini
Ubiquitination of {alpha}-Synuclein in Lewy Bodies Is a Pathological Event Not Associated with Impairment of Proteasome Function
J. Biol. Chem., November 7, 2003; 278(45): 44405 - 44411.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
A. Iwata, M. Maruyama, T. Akagi, T. Hashikawa, I. Kanazawa, S. Tsuji, and N. Nukina
Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies
Hum. Mol. Genet., October 16, 2003; 12(20): 2625 - 2635.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. A. da Costa, E. Masliah, and F. Checler
{beta}-Synuclein Displays an Antiapoptotic p53-dependent Phenotype and Protects Neurons from 6-Hydroxydopamine-induced Caspase 3 Activation: CROSS-TALK WITH {alpha}-SYNUCLEIN AND IMPLICATION FOR PARKINSON'S DISEASE
J. Biol. Chem., September 26, 2003; 278(39): 37330 - 37335.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Der-Sarkissian, C. C. Jao, J. Chen, and R. Langen
Structural Organization of {alpha}-Synuclein Fibrils Studied by Site-directed Spin Labeling
J. Biol. Chem., September 26, 2003; 278(39): 37530 - 37535.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
N. Hishikawa, J.-i. Niwa, M. Doyu, T. Ito, S. Ishigaki, Y. Hashizume, and G. Sobue
Dorfin Localizes to the Ubiquitylated Inclusions in Parkinson's Disease, Dementia with Lewy Bodies, Multiple System Atrophy, and Amyotrophic Lateral Sclerosis
Am. J. Pathol., August 1, 2003; 163(2): 609 - 619.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Ito, J.-i. Niwa, N. Hishikawa, S. Ishigaki, M. Doyu, and G. Sobue
Dorfin Localizes to Lewy Bodies and Ubiquitylates Synphilin-1
J. Biol. Chem., August 1, 2003; 278(31): 29106 - 29114.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. H. Norris, B. I. Giasson, H. Ischiropoulos, and V. M.-Y. Lee
Effects of Oxidative and Nitrative Challenges on {alpha}-Synuclein Fibrillogenesis Involve Distinct Mechanisms of Protein Modifications
J. Biol. Chem., July 11, 2003; 278(29): 27230 - 27240.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
D. M. Sampathu, B. I. Giasson, A. C. Pawlyk, J. Q. Trojanowski, and V. M.-Y. Lee
Ubiquitination of {alpha}-Synuclein Is Not Required for Formation of Pathological Inclusions in {alpha}-Synucleinopathies
Am. J. Pathol., July 1, 2003; 163(1): 91 - 100.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Ihara, H. Tomimoto, H. Kitayama, Y. Morioka, I. Akiguchi, H. Shibasaki, M. Noda, and M. Kinoshita
Association of the Cytoskeletal GTP-binding Protein Sept4/H5 with Cytoplasmic Inclusions Found in Parkinson's Disease and Other Synucleinopathies
J. Biol. Chem., June 20, 2003; 278(26): 24095 - 24102.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. Alves da Costa, E. Paitel, B. Vincent, and F. Checler
alpha -Synuclein Lowers p53-dependent Apoptotic Response of Neuronal Cells. ABOLISHMENT BY 6-HYDROXYDOPAMINE AND IMPLICATION FOR PARKINSON'S DISEASE
J. Biol. Chem., December 20, 2002; 277(52): 50980 - 50984.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Hasegawa, H. Fujiwara, T. Nonaka, K. Wakabayashi, H. Takahashi, V. M.-Y. Lee, J. Q. Trojanowski, D. Mann, and T. Iwatsubo
Phosphorylated alpha -Synuclein Is Ubiquitinated in alpha -Synucleinopathy Lesions
J. Biol. Chem., December 6, 2002; 277(50): 49071 - 49076.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
Z.-Z. Pan, W. Bruening, B. I. Giasson, V. M.-Y. Lee, and A. K. Godwin
gamma -Synuclein Promotes Cancer Cell Survival and Inhibits Stress- and Chemotherapy Drug-induced Apoptosis by Modulating MAPK Pathways
J. Biol. Chem., September 13, 2002; 277(38): 35050 - 35060.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
Y.-H. Suh and F. Checler
Amyloid Precursor Protein, Presenilins, and alpha -Synuclein: Molecular Pathogenesis and Pharmacological Applications in Alzheimer's Disease
Pharmacol. Rev., September 1, 2002; 54(3): 469 - 525.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
J.- F. Gagnon, M.- A. Bedard, M. L. Fantini, D. Petit, M. Panisset, S. Rompre, J. Carrier, and J. Montplaisir
REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease
Neurology, August 27, 2002; 59(4): 585 - 589.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. K. Lee, W. Stirling, Y. Xu, X. Xu, D. Qui, A. S. Mandir, T. M. Dawson, N. G. Copeland, N. A. Jenkins, and D. L. Price
Human alpha -synuclein-harboring familial Parkinson's disease-linked Ala-53 right-arrow Thr mutation causes neurodegenerative disease with alpha -synuclein aggregation in transgenic mice
PNAS, June 25, 2002; 99(13): 8968 - 8973.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Miake, H. Mizusawa, T. Iwatsubo, and M. Hasegawa
Biochemical Characterization of the Core Structure of alpha -Synuclein Filaments
J. Biol. Chem., May 17, 2002; 277(21): 19213 - 19219.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. G. Schlossmacher, M. P. Frosch, W. P. Gai, M. Medina, N. Sharma, L. Forno, T. Ochiishi, H. Shimura, R. Sharon, N. Hattori, et al.
Parkin Localizes to the Lewy Bodies of Parkinson Disease and Dementia with Lewy Bodies
Am. J. Pathol., May 1, 2002; 160(5): 1655 - 1667.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
M. S. Forman, M. L. Schmidt, S. Kasturi, D. P. Perl, V. M.-Y. Lee, and J. Q. Trojanowski
Tau and {alpha}-Synuclein Pathology in Amygdala of Parkinsonism-Dementia Complex Patients of Guam
Am. J. Pathol., May 1, 2002; 160(5): 1725 - 1731.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
D. Kirik, C. Rosenblad, C. Burger, C. Lundberg, T. E. Johansen, N. Muzyczka, R. J. Mandel, and A. Bjorklund
Parkinson-Like Neurodegeneration Induced by Targeted Overexpression of alpha -Synuclein in the Nigrostriatal System
J. Neurosci., April 1, 2002; 22(7): 2780 - 2791.
[Abstract] [Full Text] [PDF]

Home page